• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Brachyury 基因的表达是原发性肺癌的一个重要预后因素。

Expression of Brachyury gene is a significant prognostic factor for primary lung carcinoma.

机构信息

Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Kyushu, Japan,

出版信息

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S509-16. doi: 10.1245/s10434-013-2914-9. Epub 2013 Mar 1.

DOI:10.1245/s10434-013-2914-9
PMID:23456319
Abstract

BACKGROUND

The clinical significance of Brachyury expression and its relationship to epithelial-mesenchymal transition in primary lung carcinoma is unclear.

METHODS

Expression of Brachyury mRNA was investigated in 104 surgically resected primary lung carcinoma tissues. Immunohistochemical analysis of Brachyury transcription factor, Slug, E-cadherin, IL-8, N-cadherin, and Ki67 was performed in 67 of 104 cases, and their expression was correlated to prognoses and clinicopathological factors.

RESULTS

Brachyury mRNA expression in primary lung carcinoma tissues was a significant predictor of poor prognosis for 5-year disease-free survival and overall survival rates and was significantly correlated to vascular invasion, lymphatic permeation, histological grade, pathologic T stage, and pathologic N stage (P < 0.05). Brachyury mRNA expression was significantly inversely correlated to E-cadherin expression (P = 0.0252) and positively correlated to IL-8 protein (P = 0.0241) and to Slug protein (P = 0.0243) in adenocarcinoma tissues.

CONCLUSIONS

A positive association between Brachyury and Slug and IL-8, and a negative association with E-cadherin may lead to invasiveness and metastasis in primary lung carcinoma. Brachyury mRNA expression is a significant predictor of poor prognosis in primary lung carcinoma.

摘要

背景

Brachyury 表达的临床意义及其与原发性肺癌上皮-间充质转化的关系尚不清楚。

方法

研究了 104 例手术切除的原发性肺癌组织中 Brachyury mRNA 的表达。对 67 例中的 Brachyury 转录因子、Slug、E-钙黏蛋白、IL-8、N-钙黏蛋白和 Ki67 进行了免疫组织化学分析,并将其表达与预后和临床病理因素相关联。

结果

原发性肺癌组织中 Brachyury mRNA 的表达是 5 年无病生存率和总生存率的不良预后的显著预测因子,与血管侵犯、淋巴渗透、组织学分级、病理 T 分期和病理 N 分期显著相关(P < 0.05)。Brachyury mRNA 的表达与 E-钙黏蛋白的表达呈显著负相关(P = 0.0252),与腺癌组织中的 IL-8 蛋白(P = 0.0241)和 Slug 蛋白(P = 0.0243)呈显著正相关。

结论

Brachyury 与 Slug 和 IL-8 的正相关,与 E-钙黏蛋白的负相关可能导致原发性肺癌的侵袭和转移。Brachyury mRNA 的表达是原发性肺癌不良预后的显著预测因子。

相似文献

1
Expression of Brachyury gene is a significant prognostic factor for primary lung carcinoma.Brachyury 基因的表达是原发性肺癌的一个重要预后因素。
Ann Surg Oncol. 2013 Dec;20 Suppl 3:S509-16. doi: 10.1245/s10434-013-2914-9. Epub 2013 Mar 1.
2
The role of PTPN13 in invasion and metastasis of lung squamous cell carcinoma.PTPN13 在肺鳞癌侵袭和转移中的作用。
Exp Mol Pathol. 2013 Dec;95(3):270-5. doi: 10.1016/j.yexmp.2013.07.008. Epub 2013 Jul 29.
3
High TBX2 expression predicts poor prognosis in non-small cell lung cancer.TBX2 高表达预示非小细胞肺癌预后不良。
Neoplasma. 2014;61(4):476-80.
4
Impact of Brachyury on epithelial-mesenchymal transitions and chemosensitivity in non-small cell lung cancer.Brachyury对非小细胞肺癌上皮-间质转化及化疗敏感性的影响
Mol Med Rep. 2015 Jul;12(1):995-1001. doi: 10.3892/mmr.2015.3348. Epub 2015 Feb 13.
5
Prognostic Significance of Expression of the Epithelial-Mesenchymal Transition-Related Factor Brachyury in Intrathoracic Lymphatic Spread of Non-Small Cell Lung Cancer.上皮-间质转化相关因子Brachyury的表达在非小细胞肺癌胸内淋巴转移中的预后意义
Ann Surg Oncol. 2016 Dec;23(Suppl 5):1012-1020. doi: 10.1245/s10434-016-5530-7. Epub 2016 Sep 6.
6
Overexpression of SIP1 and downregulation of E-cadherin predict delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma after partial glossectomy.SIP1 的过表达和 E-钙黏蛋白的下调预测了部分舌切除术治疗 I/II 期口腔舌鳞癌后的颈部延迟转移。
Ann Surg Oncol. 2012 Feb;19(2):612-9. doi: 10.1245/s10434-011-2052-1. Epub 2011 Sep 13.
7
Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis.血管生成素-2信使核糖核酸在非小细胞肺癌中的过表达:与血管生成及不良预后的关联
Oncol Rep. 2004 Oct;12(4):849-53.
8
Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer.Brachyury 是上皮-间充质转化的驱动因子,在人类肺肿瘤中过表达:这为针对肺癌的新型干预提供了机会。
Clin Cancer Res. 2012 Jul 15;18(14):3868-79. doi: 10.1158/1078-0432.CCR-11-3211. Epub 2012 May 18.
9
Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis.人类肺癌中PDCD4表达缺失与肿瘤进展及预后相关。
J Pathol. 2003 Aug;200(5):640-6. doi: 10.1002/path.1378.
10
Decreased expression of ING2 gene and its clinicopathological significance in Chinese NSCLC patients.ING2 基因在中国人 NSCLC 患者中的表达降低及其临床病理意义。
Neoplasma. 2014;61(4):468-75. doi: 10.4149/neo_2014_058.

引用本文的文献

1
Chromatin Interaction and Histone Mark Signatures Associated With TBXT Expression in Metastatic Lung Cancer.与转移性肺癌中TBXT表达相关的染色质相互作用和组蛋白标记特征
Genes Chromosomes Cancer. 2025 Mar;64(3):e70041. doi: 10.1002/gcc.70041.
2
Design of an In Vitro Model for Epithelial-to-Mesenchymal Transition in Gastric Cancer.胃癌上皮-间质转化体外模型的设计
Biochem Genet. 2025 Feb;63(1):698-712. doi: 10.1007/s10528-024-10668-x. Epub 2024 Mar 20.
3
Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer.
针对头颈部癌症的 brachyury 靶向免疫疗法联合吉西他滨。
Cancer Immunol Immunother. 2023 Aug;72(8):2799-2812. doi: 10.1007/s00262-023-03460-0. Epub 2023 May 12.
4
Knockdown of Brachyury Suppresses Breast Cancer Cell Proliferation and Migration via Targeting E2F3.敲低Brachyury通过靶向E2F3抑制乳腺癌细胞增殖和迁移。
J Oncol. 2022 Nov 22;2022:7913067. doi: 10.1155/2022/7913067. eCollection 2022.
5
Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC).多靶点重组 Ad5 PSA/MUC-1/ brachyury 基免疫治疗疫苗在转移性去势抵抗性前列腺癌(mCRPC)患者中的 I 期研究。
J Immunother Cancer. 2021 Mar;9(3). doi: 10.1136/jitc-2021-002374.
6
The Role of Transcriptional Factor Brachyury on Cell Cycle Regulation in Non-small Cell Lung Cancer.转录因子Brachyury在非小细胞肺癌细胞周期调控中的作用
Front Oncol. 2020 Jul 3;10:1078. doi: 10.3389/fonc.2020.01078. eCollection 2020.
7
The Roles of Embryonic Transcription Factor BRACHYURY in Tumorigenesis and Progression.胚胎转录因子短尾相关蛋白在肿瘤发生和进展中的作用
Front Oncol. 2020 Jun 30;10:961. doi: 10.3389/fonc.2020.00961. eCollection 2020.
8
Phase I Trial of a Modified Vaccinia Ankara Priming Vaccine Followed by a Fowlpox Virus Boosting Vaccine Modified to Express Brachyury and Costimulatory Molecules in Advanced Solid Tumors.改良安卡拉牛痘疫苗(MVA)初免-禽痘病毒(FPV)加强疫苗在晚期实体瘤中的Ⅰ期临床试验:表达 brachyury 和共刺激分子的 FPV 疫苗
Oncologist. 2020 Jul;25(7):560-e1006. doi: 10.1634/theoncologist.2019-0932. Epub 2019 Dec 26.
9
Loss of the Cyclin-Dependent Kinase Inhibitor 1 in the Context of Brachyury-Mediated Phenotypic Plasticity Drives Tumor Resistance to Immune Attack.在短尾相关表型可塑性背景下细胞周期蛋白依赖性激酶抑制剂1的缺失驱动肿瘤对免疫攻击产生抗性。
Front Oncol. 2018 May 3;8:143. doi: 10.3389/fonc.2018.00143. eCollection 2018.
10
Brachyury-YAP Regulatory Axis Drives Stemness and Growth in Cancer.Brachyury-YAP 调控轴驱动癌症中的干性和生长。
Cell Rep. 2017 Oct 10;21(2):495-507. doi: 10.1016/j.celrep.2017.09.057.